[
1. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603. doi:10.1161/CIR.0000000000000 485. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
]Search in Google Scholar
[
2. O’Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC. Percutaneous device closure of patent foramen ovale for secondary stroke prevention. Circulation. 2009;119:2743–2747.doi:10.1161/CIRCULATIONAH A.109.192272. [PubMed] [CrossRef] [Google Scholar]
]Search in Google Scholar
[
3. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27:493–501. [PubMed] [Google Scholar]
]Search in Google Scholar
[
4. Finsterer J. Management of cryptogenic stroke. Acta Neurol Belg. 2010;110:135–147. [PubMed] [Google Scholar]
]Search in Google Scholar
[
5. Farb A, Ibrahim NG, Zuckerman BD. Patent foramen ovale after cryptogenic stroke—assessing the evidence for closure. N Engl J Med. 2017;377:1006–1009. [PubMed] [Google Scholar]
]Search in Google Scholar
[
6. Windecker S, Stortecky S, Meier B. Paradoxical embolism. J Am Coll Cardiol. 2014;64:403–415. [PubMed] [Google Scholar]
]Search in Google Scholar
[
7. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55:1172–1179. [PubMed] [Google Scholar]
]Search in Google Scholar
[
8. Ropper AH. Tipping point for patent foramen ovale closure. N Engl J Med. 2017;377:1093–1095. [PubMed] [Google Scholar]
]Search in Google Scholar
[
9. Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Mayo Clin Proc. 1999;74:862–869. [PubMed] [Google Scholar]
]Search in Google Scholar
[
10. Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J. 1986;112:141–145. [PubMed] [Google Scholar]
]Search in Google Scholar
[
11. Wu LA, Malouf JF, Dearani JA, et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med. 2004;164:950–956. [PubMed] [Google Scholar]
]Search in Google Scholar
[
12. Kent DM, Thaler DE. The Risk of Paradoxical Embolism (RoPE) study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Trials. 2011;12:185. [PMC free article] [PubMed] [Google Scholar]
]Search in Google Scholar
[
13. Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81:619–625. [PMC free article] [PubMed] [Google Scholar]
]Search in Google Scholar
[
14. Prefasi D, Martínez-Sánchez P, Fuentes B, Díez-Tejedor E. The utility of the RoPE score in cryptogenic stroke patients ⩽50 years in predicting a stroke-related patent foramen ovale. Int J Stroke. 2016;11:NP7–NP8. [PubMed] [Google Scholar]
]Search in Google Scholar
[
15. Shah MD. A look at atrial septal aneurysm. E-J ESC Council for Cardio Pract. 2012;10 https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-10/A-look-at-Atrial-Septal-Aneurysm. [Google Scholar]
]Search in Google Scholar
[
16. Ding C, Chang JK, Lin CC, Wu YJ, Hsieh KS. Efficacy and safety of transthoracic echocardiography alone in transcatheter closure of secundum-type atrial septal defects in adults. Echocardiography. 2016;33:579–585. [PubMed] [Google Scholar]
]Search in Google Scholar
[
17. Pinto FJ. When and how to diagnose patent foramen ovale. Heart. 2005;91:438–440. doi:10.1136/hrt.2004. 052233. [PMC free article] [PubMed] [Cross-Ref] [Google Scholar]
]Search in Google Scholar
[
18. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale. Circulation. 2002;105:2625–2631. [PubMed] [Google Scholar]
]Search in Google Scholar
[
19. Sacco RL, Prabhakaran S, Thompson JL, et al. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis. 2006;22:4–12. [PubMed] [Google Scholar]
]Search in Google Scholar
[
20. Fanouriakis A, Boumpas DT, Bertsias GK. Pathogenesis and treatment of CNS lupus. Curr Opin Rheumatol 2013;25:577–83. [10.1097/BOR.0b013e328363eaf1] [PMID: ] [PubMed] [CrossRef] [Google Scholar]
]Search in Google Scholar
[
21. Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 2011;41:1–11. [10.1016/j.semarthrit. 2010.08.001] [PMID: ] [PubMed] [Cross-Ref] [Google Scholar]
]Search in Google Scholar
[
22. Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, et al. Cerebrovascular Events in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 2018;70:1478–87. [10.1002/acr.23509] [PMID: ] [PMCID: ] [PMC free article] [PubMed] [CrossRef] [Google Scholar]
]Search in Google Scholar
[
23. Saadatnia M, Sayed-Bonakdar Z, Mohammad-Sharifi G, Sarrami AH. The necessity of stroke prevention in patients with systemic lupus erythematosus. J Res Med Sci 2012;17: 894–5. [PMID: ] [PMCID: ] [PMC free article] [PubMed] [Google Scholar]
]Search in Google Scholar
[
24. Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun 2017;76:10–20. [10.1016/j.jaut.2016.10.004] [PMID: ] [PubMed] [CrossRef] [Google Scholar]
]Search in Google Scholar
[
25. Schoenfeld SR, Kasturi S, Costenbader KH. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Semin Arthritis Rheum 2013;43:77–95. [10.1016/j.semarthrit.2012.12.0 02] [PMID:] [PubMed] [CrossRef] [Google Scholar]
]Search in Google Scholar
[
26. Mok CC, Ho LY, To CH. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus. Scand J Rheumatol 2009;38:362–8. [10.1080/03009740902776 927] [PMID: ] [PubMed] [CrossRef] [Google Scholar]
]Search in Google Scholar
